SCHEMBL20205380

SCHEMBL20205380

c1ccc2c(c1)-c1ccccc1C21c2cc3c(cc2-c2c1cc(-c1ccc4ccccc4c1)c1oc4ccccc4c21)C1(c2ccccc2-c2ccccc21)c1cc(-c2ccc4ccccc4c2)c2oc4ccccc4c2c1-3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.36
▸ ALOX5 P09917 2/20 0.36
▸ HDAC4 P56524 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ HDAC8 Q9BY41 1/20 0.34
▸ PRKDC P78527 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ CYP1A1 P04798 1/20 0.33
▸ CYP1B1 Q16678 1/20 0.33
▸ GSTP1 P09211 1/20 0.33
▸ MIF P14174 1/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205624 0.89 TDP1 (0.36) ALOX5PRKDCNPC1CYP1A2CYP2C9
SCHEMBL20205377 0.89 ALOX5 (0.36) ALOX5HDAC8CYP1A2CYP2C9CYP2C19
SCHEMBL20205633 0.88 ALOX5 (0.35) ALOX5PRKDC
SCHEMBL20205334 0.88 CDC14B (0.37) GPR84ALOX5NPC1RAB9ACYP1B1
SCHEMBL20205655 0.87 ALOX5 (0.39) ALOX5PRKDCL3MBTL1CDC14BCDC14A
SCHEMBL20205339 0.86 ALOX5 (0.37) ALOX5PRKDCNPC1RAB9ACYP1B1
SCHEMBL20205383 0.85 ALOX5 (0.36) GPR84ALOX5PRKDCCYP1A2CYP2C19
SCHEMBL20205382 0.85 CDC14B (0.34) ALOX5NPC1RAB9ACYP1B1L3MBTL1
SCHEMBL23351579 0.84 ALOX5 (0.34) ALOX5
SCHEMBL20205665 0.84 ALOX5 (0.34) ALOX5L3MBTL1CDC14BCDC14A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND GPR84 3257/4885ALOX5 354/4885HDAC4 2763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback